Clinical Trial Update: Equivalence Study to Compare Two Strengths of Creon in China [Phase 3]

View source ↗

Summary

A phase 3 equivalence study in China comparing two strengths of Creon for pancreatic insufficiency; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Insufficiency

Drugs mentioned

• Creon (pancrelipase)

Snippet

Sponsor: Abbott | Conditions: Pancreatic Insufficiency | Phase 3 | Status: UNKNOWN